Shawnte Mitchell - 18 Feb 2025 Form 3 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Signature
/s/ Shane Kovacs, Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
18 Feb 2025
Transactions value $
$0
Form type
3
Filing time
28 Feb 2025, 16:15:49 UTC
Previous filing
09 Mar 2022
Next filing
03 Mar 2025

No securities are beneficially owned.